Opposite microglial activation stages upon loss of PGRN or TREM 2 result in reduced cerebral glucose metabolism

Author:

Götzl Julia K1,Brendel Matthias2,Werner Georg1,Parhizkar Samira1,Sebastian Monasor Laura3,Kleinberger Gernot14ORCID,Colombo Alessio‐Vittorio3,Deussing Maximilian2,Wagner Matias567,Winkelmann Juliane567,Diehl‐Schmid Janine8,Levin Johannes39,Fellerer Katrin1,Reifschneider Anika1,Bultmann Sebastian10,Bartenstein Peter24,Rominger Axel24,Tahirovic Sabina3ORCID,Smith Scott T11,Madore Charlotte11,Butovsky Oleg1112,Capell Anja1ORCID,Haass Christian134ORCID

Affiliation:

1. Chair of Metabolic Biochemistry Biomedical Center (BMC) Faculty of Medicine Ludwig‐Maximilians‐Universität München Munich Germany

2. Department of Nuclear Medicine University Hospital Ludwig‐Maximilians‐Universität München Munich Germany

3. German Center for Neurodegenerative Diseases (DZNE) Munich Germany

4. Munich Cluster for Systems Neurology (SyNergy) Munich Germany

5. Institut für Neurogenomik Helmholtz Zentrum München Munich Germany

6. Institut of Human Genetics Technische Universität München Munich Germany

7. Institute of Human Genetics Helmholtz Zentrum München Neuherberg Germany

8. Department of Psychiatry Technische Universität München Munich Germany

9. Department of Neurology University Hospital Ludwig‐Maximilians‐Universität München Munich Germany

10. Department of Biology and Center for Integrated Protein Science Munich (CIPSM) Ludwig Maximilians‐Universität München Munich Germany

11. Ann Romney Center for Neurologic Diseases Department of Neurology Brigham and Women′s Hospital Harvard Medical School Boston MA USA

12. Evergrande Center for Immunologic Diseases Brigham and Women's Hospital Harvard Medical School Boston MA USA

Funder

National Institute of Neurological Disorders and Stroke

Cure Alzheimer's Fund

Amyotrophic Lateral Sclerosis Association

Bundesministerium für Bildung und Forschung

National Institutes of Health

National Institute on Aging

Deutsche Forschungsgemeinschaft

National Multiple Sclerosis Society

Sanofi

Publisher

EMBO

Subject

Molecular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3